Clinical Trial Update: Long-term Open-label Trial in Idiopathic Restless Legs Syndrome (RLS) [Phase 2]

View source ↗

Summary

This is a long-term open-label Phase 2 trial in idiopathic Restless Legs Syndrome conducted by UCB Pharma. The study is completed and results were posted in Apr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Restless Legs Syndrome

Snippet

Sponsor: UCB Pharma | Conditions: Restless Legs Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2010-04-13